{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:26:27Z","timestamp":1762917987940,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000070","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["T32 EB000814","R01-EB018645"],"award-info":[{"award-number":["T32 EB000814","R01-EB018645"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA201328","R01 CA129176"],"award-info":[{"award-number":["R01 CA201328","R01 CA129176"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["2209215"],"award-info":[{"award-number":["2209215"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr&amp;#x00E5;d","doi-asserted-by":"publisher","award":["239940 and 228879"],"award-info":[{"award-number":["239940 and 228879"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health &amp; Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["S10 OD010688"],"award-info":[{"award-number":["S10 OD010688"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"U.S. Department of Health &amp; Human Services | NIH | National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1 RR024134"],"award-info":[{"award-number":["UL1 RR024134"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cytosolic phospholipase A2\u03b1 (cPLA2\u03b1) has been shown to be elevated in breast cancer and is a potential biomarker in the differentiation of molecular sub-types. Using a cPLA2\u03b1 activatable fluorophore, DDAO arachidonate, we explore its ability to function as a contrast agent in fluorescence-guided surgery. In cell lines ranging in cPLA2\u03b1 expression and representing varying breast cancer sub-types, we show DDAO arachidonate activates with a high correlation to cPLA2\u03b1 expression level. Using a control probe, DDAO palmitate, in addition to cPLA2\u03b1 inhibition and genetic knockdown, we show that this activation is a result of cPLA2\u03b1 activity. In mouse models, using an <jats:italic>ex vivo<\/jats:italic> tumor painting technique, we show that DDAO arachidonate activates to a high degree in basal-like versus luminal-like breast tumors and healthy mammary tissue. Finally, we show that using an <jats:italic>in vivo<\/jats:italic> model, orthotopic basal-like tumors give significantly high probe activation compared to healthy mammary fat pads and surrounding tissue. Together we conclude that cPLA2\u03b1 activatable fluorophores such as DDAO arachidonate may serve as a useful contrast agent for the visualization of tumor margins in the fluorescence-guided surgery of basal-like breast cancer.<\/jats:p>","DOI":"10.1038\/s41598-019-41626-y","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T10:03:21Z","timestamp":1555409001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Detection and Differentiation of Breast Cancer Sub-Types using a cPLA2\u03b1 Activatable Fluorophore"],"prefix":"10.1038","volume":"9","author":[{"given":"Michael G.","family":"Chiorazzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6960-2112","authenticated-orcid":false,"given":"Hanna Maja","family":"Tunset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoliy V.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siver","family":"Moestue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. James","family":"Delikatny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"key":"41626_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.athoracsur.2016.08.079","volume":"103","author":"J Keating","year":"2017","unstructured":"Keating, J. et al. Near-Infrared Intraoperative Molecular Imaging Can Locate Metastases to the Lung. Annals of Thoracic Surgery 103, 390\u2013398, https:\/\/doi.org\/10.1016\/j.athoracsur.2016.08.079 (2017).","journal-title":"Annals of Thoracic Surgery"},{"key":"41626_CR2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrc3566","volume":"13","author":"QT Nguyen","year":"2013","unstructured":"Nguyen, Q. T. & Tsien, R. Y. Fluorescence-guided surgery with live molecular navigation\u2013a new cutting edge. Nat Rev Cancer 13, 653\u2013662, https:\/\/doi.org\/10.1038\/nrc3566 (2013).","journal-title":"Nat Rev Cancer"},{"key":"41626_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3171\/jns.2003.99.3.0597","volume":"99","author":"J Shinoda","year":"2003","unstructured":"Shinoda, J. et al. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg 99, 597\u2013603, https:\/\/doi.org\/10.3171\/jns.2003.99.3.0597 (2003).","journal-title":"Technical note. J Neurosurg"},{"key":"41626_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nm.2472","volume":"17","author":"GM van Dam","year":"2011","unstructured":"van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med 17, 1315\u20131319, https:\/\/doi.org\/10.1038\/nm.2472 (2011).","journal-title":"Nat Med"},{"key":"41626_CR5","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/lary.24102","volume":"123","author":"KE Day","year":"2013","unstructured":"Day, K. E. et al. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope 123, 2681\u20132689, https:\/\/doi.org\/10.1002\/lary.24102 (2013).","journal-title":"Laryngoscope"},{"key":"41626_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer, W. et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7, 392\u2013401, https:\/\/doi.org\/10.1016\/S1470-2045(06)70665-9 (2006).","journal-title":"Lancet Oncol"},{"key":"41626_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jso.24167","volume":"113","author":"J Keating","year":"2016","unstructured":"Keating, J. et al. Identification of breast cancer margins using intraoperative near-infrared imaging. J Surg Oncol 113, 508\u2013514, https:\/\/doi.org\/10.1002\/jso.24167 (2016).","journal-title":"J Surg Oncol"},{"key":"41626_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep16208","volume":"5","author":"RP Judy","year":"2015","unstructured":"Judy, R. P. et al. Quantification of tumor fluorescence during intraoperative optical cancer imaging. Sci Rep 5, 16208, https:\/\/doi.org\/10.1038\/srep16208 (2015).","journal-title":"Sci Rep"},{"key":"41626_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cbpa.2018.03.002","volume":"45","author":"PS Low","year":"2018","unstructured":"Low, P. S., Singhal, S. & Srinivasarao, M. Fluorescence-guided surgery of cancer: applications, tools and perspectives. Curr. Opin. Chem. Biol. 45, 64\u201372, https:\/\/doi.org\/10.1016\/j.cbpa.2018.03.002 (2018).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"41626_CR10","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1021\/acs.jmedchem.8b01115","volume":"61","author":"SM Mahalingam","year":"2018","unstructured":"Mahalingam, S. M. et al. Evaluation of Novel Tumor-Targeted Near-Infrared Probe for Fluorescence-Guided Surgery of Cancer. J. Med. Chem. 61, 9637\u20139646, https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01115 (2018).","journal-title":"J. Med. Chem."},{"key":"41626_CR11","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/cncr.11222","volume":"97","author":"F Meric","year":"2003","unstructured":"Meric, F. et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97, 926\u2013933, https:\/\/doi.org\/10.1002\/cncr.11222 (2003).","journal-title":"Cancer"},{"key":"41626_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE DeSantis","year":"2014","unstructured":"DeSantis, C. E. et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64, 252\u2013271, https:\/\/doi.org\/10.3322\/caac.21235 (2014).","journal-title":"CA Cancer J Clin"},{"key":"41626_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0002-9610(02)01012-7","volume":"184","author":"SE Singletary","year":"2002","unstructured":"Singletary, S. E. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184, 383\u2013393 (2002).","journal-title":"Am J Surg"},{"key":"41626_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrclinonc.2013.123","volume":"10","author":"AL Vahrmeijer","year":"2013","unstructured":"Vahrmeijer, A. L., Hutteman, M., van der Vorst, J. R., van de Velde, C. J. & Frangioni, J. V. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10, 507\u2013518, https:\/\/doi.org\/10.1038\/nrclinonc.2013.123 (2013).","journal-title":"Nat Rev Clin Oncol"},{"key":"41626_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jso.21943","volume":"104","author":"BE Schaafsma","year":"2011","unstructured":"Schaafsma, B. E. et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 104, 323\u2013332, https:\/\/doi.org\/10.1002\/jso.21943 (2011).","journal-title":"J Surg Oncol"},{"key":"41626_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","volume":"65","author":"H Maeda","year":"2000","unstructured":"Maeda, H., Wu, J., Sawa, T., Matsumura, Y. & Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65, 271\u2013284 (2000).","journal-title":"J Control Release"},{"key":"41626_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/86684","volume":"19","author":"R Weissleder","year":"2001","unstructured":"Weissleder, R. A clearer vision for in vivo imaging. Nat Biotechnol 19, 316\u2013317, https:\/\/doi.org\/10.1038\/86684 (2001).","journal-title":"Nat Biotechnol"},{"key":"41626_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1021\/bc0340114","volume":"14","author":"WK Moon","year":"2003","unstructured":"Moon, W. K. et al. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug Chem 14, 539\u2013545, https:\/\/doi.org\/10.1021\/bc0340114 (2003).","journal-title":"Bioconjug Chem"},{"key":"41626_CR19","first-page":"7870","volume":"63","author":"S Ke","year":"2003","unstructured":"Ke, S. et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63, 7870\u20137875 (2003).","journal-title":"Cancer Res"},{"key":"41626_CR20","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.2967\/jnumed.111.092833","volume":"52","author":"AG Terwisscha van Scheltinga","year":"2011","unstructured":"Terwisscha van Scheltinga, A. G. et al. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med 52, 1778\u20131785, https:\/\/doi.org\/10.2967\/jnumed.111.092833 (2011).","journal-title":"J Nucl Med"},{"key":"41626_CR21","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1158\/1535-7163.MCT-14-0085","volume":"13","author":"SP Arlauckas","year":"2014","unstructured":"Arlauckas, S. P., Popov, A. V. & Delikatny, E. J. Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine. Mol Cancer Ther 13, 2149\u20132158, https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0085 (2014).","journal-title":"Mol Cancer Ther"},{"key":"41626_CR22","doi-asserted-by":"publisher","unstructured":"Arlauckas, S. P., Kumar, M., Popov, A. V., Poptani, H. & Delikatny, E. J. Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors. Oncotarget, https:\/\/doi.org\/10.18632\/oncotarget.14965 (2017).","DOI":"10.18632\/oncotarget.14965"},{"key":"41626_CR23","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1073\/pnas.0401354101","volume":"101","author":"H Murakoshi","year":"2004","unstructured":"Murakoshi, H. et al. Single-molecule imaging analysis of Ras activation in living cells. Proc Natl Acad Sci USA 101, 7317\u20137322, https:\/\/doi.org\/10.1073\/pnas.0401354101 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41626_CR24","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/35082594","volume":"411","author":"N Mochizuki","year":"2001","unstructured":"Mochizuki, N. et al. Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature 411, 1065\u20131068, https:\/\/doi.org\/10.1038\/35082594 (2001).","journal-title":"Nature"},{"key":"41626_CR25","doi-asserted-by":"crossref","unstructured":"Gao, Q. et al. PLA2-responsive and SPIO-loaded phospholipid micelles. Chem Commun (Camb) 51, 12313\u201312315, doi:10.1039\/c5cc04540a (2015).","DOI":"10.1039\/C5CC04540A"},{"key":"41626_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/7933","volume":"17","author":"R Weissleder","year":"1999","unstructured":"Weissleder, R., Tung, C. H., Mahmood, U. & Bogdanov, A. Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17, 375\u2013378, https:\/\/doi.org\/10.1038\/7933 (1999).","journal-title":"Nat Biotechnol"},{"key":"41626_CR27","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1021\/bc200242v","volume":"22","author":"TM Mawn","year":"2011","unstructured":"Mawn, T. M. et al. In vivo detection of phospholipase C by enzyme-activated near-infrared probes. Bioconjug Chem 22, 2434\u20132443, https:\/\/doi.org\/10.1021\/bc200242v (2011).","journal-title":"Bioconjug Chem"},{"key":"41626_CR28","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1021\/bc100271v","volume":"21","author":"AV Popov","year":"2010","unstructured":"Popov, A. V., Mawn, T. M., Kim, S., Zheng, G. & Delikatny, E. J. Design and synthesis of phospholipase C and A2-activatable near-infrared fluorescent smart probes. Bioconjug Chem 21, 1724\u20131727, https:\/\/doi.org\/10.1021\/bc100271v (2010).","journal-title":"Bioconjug Chem"},{"key":"41626_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ab.2011.12.009","volume":"422","author":"TM Mawn","year":"2012","unstructured":"Mawn, T. M., Popov, A. V. & Delikatny, E. J. A quantitative continuous enzyme assay of intramolecularly quenched fluorogenic phospholipase substrates for molecular imaging. Anal Biochem 422, 96\u2013102, https:\/\/doi.org\/10.1016\/j.ab.2011.12.009 (2012).","journal-title":"Anal Biochem"},{"issue":"1","key":"41626_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1021\/acs.bioconjchem.8b00820","volume":"30","author":"Fusa Ogata","year":"2018","unstructured":"Ogata, F. et al. Activatable Near-Infrared Fluorescence Imaging Using PEGylated Bacteriochlorin-Based Chlorin and BODIPY-Dyads as Probes for Detecting Cancer. Bioconjugate Chem. Ahead of Print, https:\/\/doi.org\/10.1021\/acs.bioconjchem.8b00820 (2018).","journal-title":"Bioconjugate Chemistry"},{"issue":"6","key":"41626_CR31","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1021\/acsomega.8b00635","volume":"3","author":"Benjamin K. Liebov","year":"2018","unstructured":"Liebov, B. K. et al. Nonprotecting Group Synthesis of a Phospholipase C Activatable Probe with an Azo-Free Quencher. ACS Omega 3, 6867\u20136873, https:\/\/doi.org\/10.1021\/acsomega.8b00635 (2018).","journal-title":"ACS Omega"},{"key":"41626_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.copbio.2007.01.003","volume":"18","author":"J Rao","year":"2007","unstructured":"Rao, J., Dragulescu-Andrasi, A. & Yao, H. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 18, 17\u201325, https:\/\/doi.org\/10.1016\/j.copbio.2007.01.003 (2007).","journal-title":"Curr Opin Biotechnol"},{"key":"41626_CR33","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1073\/pnas.051635898","volume":"98","author":"KH Hong","year":"2001","unstructured":"Hong, K. H., Bonventre, J. C., O\u2019Leary, E., Bonventre, J. V. & Lander, E. S. Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis. Proc Natl Acad Sci USA 98, 3935\u20133939, https:\/\/doi.org\/10.1073\/pnas.051635898 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41626_CR34","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/carcin\/bgh150","volume":"25","author":"AM Meyer","year":"2004","unstructured":"Meyer, A. M. et al. Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis 25, 1517\u20131524, https:\/\/doi.org\/10.1093\/carcin\/bgh150 (2004).","journal-title":"Carcinogenesis"},{"key":"41626_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.plipres.2010.12.001","volume":"50","author":"M Murakami","year":"2011","unstructured":"Murakami, M. et al. Recent progress in phospholipase A(2) research: from cells to animals to humans. Prog Lipid Res 50, 152\u2013192, https:\/\/doi.org\/10.1016\/j.plipres.2010.12.001 (2011).","journal-title":"Prog Lipid Res"},{"key":"41626_CR36","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1210\/me.2009-0293","volume":"24","author":"F Caiazza","year":"2010","unstructured":"Caiazza, F., Harvey, B. J. & Thomas, W. Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth. Mol Endocrinol 24, 953\u2013968, https:\/\/doi.org\/10.1210\/me.2009-0293 (2010).","journal-title":"Mol Endocrinol"},{"key":"41626_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/sj.bjc.6606025","volume":"104","author":"F Caiazza","year":"2011","unstructured":"Caiazza, F. et al. Cytosolic phospholipase A2-alpha expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours. Br J Cancer 104, 338\u2013344, https:\/\/doi.org\/10.1038\/sj.bjc.6606025 (2011).","journal-title":"Br J Cancer"},{"key":"41626_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-433","volume":"10","author":"SA Moestue","year":"2010","unstructured":"Moestue, S. A. et al. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer 10, 433, https:\/\/doi.org\/10.1186\/1471-2407-10-433 (2010).","journal-title":"BMC Cancer"},{"key":"41626_CR39","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyoerffy","year":"2010","unstructured":"Gyoerffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123, 725\u2013731, https:\/\/doi.org\/10.1007\/s10549-009-0674-9 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"41626_CR40","doi-asserted-by":"publisher","first-page":"191\/191","DOI":"10.1186\/s12885-016-2225-1","volume":"16","author":"E Kim","year":"2016","unstructured":"Kim, E. et al. Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. BMC Cancer 16, 191\/191\u2013191\/111, https:\/\/doi.org\/10.1186\/s12885-016-2225-1 (2016).","journal-title":"BMC Cancer"},{"key":"41626_CR41","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1021\/acs.bioconjchem.5b00417","volume":"26","author":"MG Chiorazzo","year":"2015","unstructured":"Chiorazzo, M. G., Bloch, N. B., Popov, A. V. & Delikatny, E. J. Synthesis and Evaluation of Cytosolic Phospholipase A(2) Activatable Fluorophores for Cancer Imaging. Bioconjug Chem 26, 2360\u20132370, https:\/\/doi.org\/10.1021\/acs.bioconjchem.5b00417 (2015).","journal-title":"Bioconjug Chem"},{"key":"41626_CR42","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518\u2013524, https:\/\/doi.org\/10.1038\/nature03799 (2005).","journal-title":"Nature"},{"key":"41626_CR43","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1432-1033.1996.t01-1-00533.x","volume":"236","author":"M Enari","year":"1996","unstructured":"Enari, M. et al. Different apoptotic pathways mediated by Fas and the tumor-necrosis-factor receptor. Cytosolic phospholipase A2 is not involved in Fas-mediated apoptosis. Eur J Biochem 236, 533\u2013538 (1996).","journal-title":"Eur J Biochem"},{"key":"41626_CR44","doi-asserted-by":"publisher","first-page":"27369","DOI":"10.1074\/jbc.M800696200","volume":"283","author":"A Gubern","year":"2008","unstructured":"Gubern, A. et al. Group IVA phospholipase A2 is necessary for the biogenesis of lipid droplets. J Biol Chem 283, 27369\u201327382, https:\/\/doi.org\/10.1074\/jbc.M800696200 (2008).","journal-title":"J Biol Chem"},{"key":"41626_CR45","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.bbalip.2014.10.004","volume":"1841","author":"C Guijas","year":"2014","unstructured":"Guijas, C., Rodriguez, J. P., Rubio, J. M., Balboa, M. A. & Balsinde, J. Phospholipase A2 regulation of lipid droplet formation. Biochim Biophys Acta 1841, 1661\u20131671, https:\/\/doi.org\/10.1016\/j.bbalip.2014.10.004 (2014).","journal-title":"Biochim Biophys Acta"},{"key":"41626_CR46","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/nbm.1661","volume":"24","author":"EJ Delikatny","year":"2011","unstructured":"Delikatny, E. J., Chawla, S., Leung, D. J. & Poptani, H. MR-visible lipids and the tumor microenvironment. NMR Biomed 24, 592\u2013611, https:\/\/doi.org\/10.1002\/nbm.1661 (2011).","journal-title":"NMR Biomed"},{"key":"41626_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(99)00037-X","volume":"40","author":"N Duzgunes","year":"1999","unstructured":"Duzgunes, N. & Nir, S. Mechanisms and kinetics of liposome-cell interactions. Adv. Drug Delivery Rev. 40, 3\u201318, https:\/\/doi.org\/10.1016\/S0169-409X(99)00037-X (1999).","journal-title":"Adv. Drug Delivery Rev."},{"key":"41626_CR48","first-page":"507","volume":"4","author":"N Anikeeva","year":"2014","unstructured":"Anikeeva, N., Sykulev, Y., Delikatny, E. J. & Popov, A. V. Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents. Am. J. Nucl. Med. Mol. Imaging 4, 507\u2013524 (2014).","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"41626_CR49","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1039\/C5CC08764C","volume":"52","author":"SR Levine","year":"2016","unstructured":"Levine, S. R. & Beatty, K. E. Synthesis of a far-red fluorophore and its use as an esterase probe in living cells. Chem. Commun. (Cambridge, U. K.) 52, 1835\u20131838, https:\/\/doi.org\/10.1039\/C5CC08764C (2016).","journal-title":"Chem. Commun. (Cambridge, U. K.)"},{"key":"41626_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0005-2736(93)90115-G","volume":"1150","author":"TM Allen","year":"1993","unstructured":"Allen, T. M., Hansen, C. B. & Guo, L. S. S. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim. Biophys. Acta, Biomembr. 1150, 9\u201316, https:\/\/doi.org\/10.1016\/0005-2736(93)90115-G (1993).","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"key":"41626_CR51","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1364\/OE.15.006696","volume":"15","author":"A Corlu","year":"2007","unstructured":"Corlu, A. et al. Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt Express 15, 6696\u20136716 (2007).","journal-title":"Opt Express"},{"key":"41626_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3485","volume":"15","author":"A Leproux","year":"2013","unstructured":"Leproux, A. et al. Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI). Breast Cancer Res 15, R89, https:\/\/doi.org\/10.1186\/bcr3485 (2013).","journal-title":"Breast Cancer Res"},{"key":"41626_CR53","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1088\/0031-9155\/47\/16\/302","volume":"47","author":"T Durduran","year":"2002","unstructured":"Durduran, T. et al. Bulk optical properties of healthy female breast tissue. Phys Med Biol 47, 2847\u20132861 (2002).","journal-title":"Phys Med Biol"},{"key":"41626_CR54","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1364\/OL.30.002915","volume":"30","author":"T Durduran","year":"2005","unstructured":"Durduran, T. et al. Diffuse optical measurement of blood flow in breast tumors. Opt Lett 30, 2915\u20132917 (2005).","journal-title":"Opt Lett"},{"key":"41626_CR55","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1073\/pnas.071511098","volume":"98","author":"N Shah","year":"2001","unstructured":"Shah, N. et al. Noninvasive functional optical spectroscopy of human breast tissue. Proc. Natl. Acad. Sci. USA 98, 4420\u20134425, https:\/\/doi.org\/10.1073\/pnas.071511098 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"41626_CR56","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1021\/jm500192s","volume":"57","author":"G Kokotos","year":"2014","unstructured":"Kokotos, G. et al. Inhibition of Group IVA Cytosolic Phospholipase A2 by Thiazolyl Ketones in Vitro, ex Vivo, and in Vivo. J. Med. Chem. 57, 7523\u20137535, https:\/\/doi.org\/10.1021\/jm500192s (2014).","journal-title":"J. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41626-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41626-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41626-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:44:29Z","timestamp":1671266669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41626-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41626"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41626-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"assertion":[{"value":"23 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B. Johansen has ownership interests (including patents) in Avexxin AS.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6122"}}